14/03/2024
Updates from the European Medicines Agency (EMA) shed light on the recent revision of the QRD Templates, particularly tailored to comply with QRD template v10.4 updated on 29/02/2024, addressing the regulatory implications post-Br
21/02/2024
Hey everyone in the regulatory and pharmaceutical world!Just dropping in to share the latest scoop from EMA: they've rolled out an update of the guidance on electronic submission of information for investigational medicinal produc
17/01/2024
Happy New Year 2024! As we step into this bright new year, all of us at AxeRegel extend our warmest wishes to our valued partners, clients, and the entire healthcare community.2023 was a remarkable year, filled with challenge
01/11/2023
In the dynamic world of pharmaceuticals, it's imperative for pharmaceutical companies to remain informed about new developments that prioritize patient safety and promote responsible medication use. Today, we're shedding light on
18/10/2023
Hello, fellow healthcare enthusiasts and pharmaceutical professionals! The European Medicines Agency (EMA) has just dropped a new set of answers in their post-authorisation procedural advice! If you're not already in the